Daniel Johnston
Abstract
Valproic acid (VPA; 2‐propylpentanoic acid or dipropylacetic acid) was synthesized by Burton in 1882 and shown to have anticonvulsant properties by Meunier et al. in 1963. VPA was licensed for use as an anticonvulsant in the United States in 1978. It is used primarily for the treatment of generalized seizures.
OpenAlex reports 62 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Valproic acid (VPA; 2‐propylpentanoic acid or dipropylacetic acid) was synthesized by Burton in 1882 and shown to have anticonvulsant properties by Meunier et al. in 1963. VPA was licensed for use as an anticonvulsant in the United States in 1978. It is used primarily for the treatment of generalized seizures.
Key concepts: Valproic Acid, Anticonvulsant, Pharmacology, Epilepsy, Chemistry, Medicine, Psychiatry